In our ADITL era 💁‍♀️ today we get a peek into the life of Monica Mahoney (Monica Mahoney) at Beth Israel Deaconess Medical Center (@bidmcpharmres)! Have we mentioned #IDPharmacistsDay is May 22??

Curious what type of coverage the newer antifungals have? 🧐 Check out these summary tables ⬇️ from Melissa Johnson! #MADID2024

Dr Bonomo at MAD-ID The Antimicrobial Stewardship Meeting®️ #MADID2024 : BL/BLI combinations are like a marriage- if you don’t have the right partner it doesn’t work

Melissa Johnson raising the alarm 🚨 on fungicidal use in AGRICULTURE driving antifungal resistance in HUMAN infection 😬 #MADID2024

Using EPIC features, pharmacists are able to quickly & efficiently be notified of and review discharge antibiotic prescriptions for patients in order to improve outpatient stewardship. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Ron Welch

Ceftriaxone may be a viable option for the treatment of low-risk AmpC Enterobacterales. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Jessy Anita Bee Bacillus

More than half of patients experienced thrombocytopenia during linezolid administration. Patients on linezolid for > 10 days should be monitored closely for thrombocytopenia & evaluated for ways to limit this risk. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Krysten McNaught Kate DeSear

Be sure to check out the poster from yesterday's platform presentation! The study demonstrated the effectiveness of oral antibiotics in the treatment of GN BSIs in SOT recipients. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP @Boo_saw_lah @Krutu8 Taymorrisette Rachel Burgoon Aaron Hamby

Team echinocandin or team fluconazole for Candida glabrata? Visit the poster session to discuss fluconazole step-down therapy versus echinocandin therapy for Candida glabrata candidemia! #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Madeline Droney

Check out this case report on navigating isavuconazole drug monitoring while on ECMO. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Blain Thayer, PharmD, AAHIVP Taylor Steuber Taylor Nelson, DO

This survey describes the AMS practices currently employed by OPAT programs across the US. Institutions may reference the results to advance the AMS practices of their OPAT programs to meet TJC Outpatient AMS standards. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Sara Azimi, PharmD

The combination of education, local guidelines, and EHR optimization was shown to be an effective approach as an antimicrobial stewardship intervention to reduce and sustain inappropriate dosing of oral vancomycin for CDI. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Jordan Chiasson

Pharmacists engaged in transitions of care improved antibiotic selection and duration of therapy at time of discharge. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Bug Pharmacist 💊🧫 Tim Gauthier

A workflow for fidaxomicin in transitions of care led to access improvements and was associated with greater fidaxomicin use. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Bug Pharmacist 💊🧫 Tim Gauthier thomas liu

Pneumonia panel implementation led to increased de-escalation and escalation of antimicrobial therapy. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Bug Pharmacist 💊🧫 Tim Gauthier

Upper respiratory tract infection stewardship in urgent care can be a great starting point for programs looking to implement outpatient antimicrobial stewardship #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Maxx Enzmann

In a retrospective study, there was no difference in outcomes including 30 day mortality between linezolid and clindamycin in GAS infections. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Bailey Garner, PharmD

Utilization of OABP in patients undergoing colorectal surgery lead to reduced rates of SSIs, decreased LOS, and no increased incidence in CDI. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Caitlin Ellis

Patients at high-risk of progression w/ COVID-19 who were hospitalized & received 3-day remdesivir or Paxlovid had similar rates of disease progression, LOS, readmissions, & mortality. #MADID2024 MAD-ID The Antimicrobial Stewardship Meeting®️ SIDP Madeline Belk Taylor Steuber Jonathan Edwards

RUN , don’t walk, to learn more about NHSN with Libby Dodds Ashley !! (seriously she is awesome!). Want to learn about how to use NHSN data to identify stewardship opportunities? Swipe right for how to access ‘How To’ videos & pdfs on dason.medicine.duke.edu #MADID2024 #NHSN CDC Antimicrobial Resistance